(0.16%) 5 139.75 points
(0.11%) 38 483 points
(0.26%) 17 892 points
(-0.19%) $83.69
(0.83%) $1.939
(0.30%) $2 354.20
(0.54%) $27.68
(1.67%) $937.50
(-0.17%) $0.933
(-0.30%) $10.99
(-0.29%) $0.798
(1.23%) $93.00
-0.02% ¥ 2 487.50
Live Chart Being Loaded With Signals
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs...
Stats | |
---|---|
Tagesvolumen | 1.10M |
Durchschnittsvolumen | 1.66M |
Marktkapitalisierung | 1 550.87B |
EPS | ¥0 ( 2024-02-08 ) |
Nächstes Ertragsdatum | ( ¥25.37 ) 2024-05-08 |
Last Dividend | ¥2.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 34.60 |
ATR14 | ¥1.939 (0.08%) |
Volumen Korrelation
Sysmex Corporation Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Sysmex Corporation Korrelation - Währung/Rohstoff
Sysmex Corporation Finanzdaten
Annual | 2022 |
Umsatz: | ¥410.50B |
Bruttogewinn: | ¥216.08B (52.64 %) |
EPS: | ¥72.94 |
FY | 2022 |
Umsatz: | ¥410.50B |
Bruttogewinn: | ¥216.08B (52.64 %) |
EPS: | ¥72.94 |
FY | 2022 |
Umsatz: | ¥363.78B |
Bruttogewinn: | ¥190.59B (52.39 %) |
EPS: | ¥210.88 |
FY | 2021 |
Umsatz: | ¥305.07B |
Bruttogewinn: | ¥154.30B (50.58 %) |
EPS: | ¥158.65 |
Financial Reports:
No articles found.
Sysmex Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥40.00 (N/A) |
¥0 (N/A) |
¥2.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥1.500 | 2001-03-27 |
Last Dividend | ¥2.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 46 | -- |
Total Paid Out | ¥628.25 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.35 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.53 | |
Div. Directional Score | 9.65 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8142.T | Ex Dividend Knight | 2024-01-30 | Annually | 0 | 0.00% | |
7506.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6727.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
6071.T | Ex Dividend Knight | 2023-12-28 | Annually | 0 | 0.00% | |
4746.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3988.T | Ex Dividend Junior | 2024-07-30 | Annually | 0 | 0.00% | |
3197.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
2201.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
9065.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7949.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.103 | 1.500 | 7.94 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0794 | 1.200 | 7.35 | 8.82 | [0 - 0.3] |
returnOnEquityTTM | 0.112 | 1.500 | 9.87 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.390 | -1.000 | 6.10 | -6.10 | [0 - 1] |
currentRatioTTM | 3.10 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.972 | 0.800 | 3.11 | 2.49 | [0.8 - 2.5] |
cashRatioTTM | 0.603 | 1.500 | 7.76 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0882 | -1.500 | 8.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 37.92 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 108.38 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 28.58 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.123 | -1.500 | 9.51 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.532 | 1.000 | 4.47 | 4.47 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.168 | 1.000 | 8.65 | 8.65 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.355 | 1.000 | 3.58 | 3.58 | [0.2 - 2] |
assetTurnoverTTM | 0.773 | 0.800 | 8.18 | 6.55 | [0.5 - 2] |
Total Score | 12.77 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 34.55 | 1.000 | 6.61 | 0 | [1 - 100] |
returnOnEquityTTM | 0.112 | 2.50 | 9.92 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 28.58 | 2.00 | 0.474 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.25 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 108.38 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.390 | 1.500 | 6.10 | -6.10 | [0 - 1] |
pegRatioTTM | 0.907 | 1.500 | 7.28 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.155 | 1.000 | 8.63 | 0 | [0.1 - 0.5] |
Total Score | 6.53 |
Sysmex Corporation
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.